Ignite Creation Date:
2024-05-06 @ 8:58 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02865434
Status:
COMPLETED
Last Update Posted:
2021-08-12
First Post:
2016-08-05
Brief Title:
Evaluating Safety of Escalating Doses of Tilmanocept by IV Injection and SPECT Imaging in Subjects With and Without RA
Sponsor:
Navidea Biopharmaceuticals
Organization:
Navidea Biopharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Arthritis Rheumatoid |
Keywords: